about
Computational design of a PDZ domain peptide inhibitor that rescues CFTR activityRegulation of c-Src by binding to the PDZ domain of AF-6Identification of Xin-repeat proteins as novel ligands of the SH3 domains of nebulin and nebulette and analysis of their interaction during myofibril formation and remodelingStereochemical Preferences Modulate Affinity and Selectivity among Five PDZ Domains that Bind CFTR: Comparative Structural and Sequence AnalysesCtpB Assembles a Gated Protease Tunnel Regulating Cell-Cell Signaling during Spore Formation in Bacillus subtilisDomain Interaction Footprint: a multi-classification approach to predict domain-peptide interactions.Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.A retro-inverso cell-penetrating peptide for siRNA delivery.Identification of a linear epitope in sortilin that partakes in pro-neurotrophin binding.Characterization of a putative phosphorylation switch: adaptation of SPOT synthesis to analyze PDZ domain regulation mechanisms.Using hydroxymethylphenoxy derivates with the SPOT technology to generate peptides with authentic C-termini.Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping EfficiencyChemical biology approaches reveal conserved features of a C-terminal processing PDZ protease.Discovery of low-molecular-weight ligands for the AF6 PDZ domain.Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells.Delivery of therapeutic oligonucleotides with cell penetrating peptides.Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo.Comparison of cellular uptake using 22 CPPs in 4 different cell lines.Generation and characterization of a rat monoclonal antibody specific for PCNA.In Vitro Assays to Assess Exon Skipping in Duchenne Muscular Dystrophy.A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR.Involvement of 14-3-3 protein post-translational modifications in Giardia duodenalis encystation.Sorting and pooling strategy: a novel tool to map a virus proteome for CD8 T-cell epitopes.Cardiac mGluR1 metabotropic receptors in cardioprotection.Optimization of the process of inverted peptides (PIPEPLUS) to screen PDZ domain ligands.PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.RNase H-Assisted Imaging of Peroxynitrite in Living Cells with 5′-Boronic Acid Modified DNAHow to evaluate the cellular uptake of CPPs with fluorescence techniques: Dissecting methodological pitfalls associated to tryptophan-rich peptidesOptimization of peptide-plasmid DNA vectors formulation for gene delivery in cancer therapy exploring design of experiments
P50
Q21145315-3BECA56D-8F2F-4B48-8217-5973B50591C3Q24305219-A67F7AA9-F578-490E-82CE-6B254637E72AQ27679820-ADF1BA34-0125-443E-80C3-AA87BCF57BB4Q27680564-100B3871-00AF-4627-B0E3-9794B85112EBQ27680619-923564E2-C763-48E3-BF8D-B47C2E6CE3A3Q30157294-79725705-B0B8-4EDA-88E6-CF100479DD38Q30163803-32F4696D-2C96-49BE-A0C9-AF51A53D8C85Q30847307-43857E7E-3306-4E77-B989-95307C0A554AQ30977865-087444DC-74B5-4EBF-B2CF-6F18913CE9C6Q33304541-34402DE0-3713-4405-BEE9-6245BF46C7C0Q33345092-38D37491-024D-4D92-A469-14F449EB2BD5Q33637391-B85E00B3-929A-466B-ACAF-A18D516F2152Q34135453-BEE1A1A8-26BF-4B88-B795-36516BD6EC08Q34521390-EA0B29D8-2E3A-4EF0-ABC7-157CDBE01CE4Q37631779-AF4A6263-E798-49C1-8CF8-BD3AF01BFCD9Q38369597-C1F8A678-4D65-4369-94B7-32BECED67029Q38768534-D60F4DBB-0C67-4139-83F1-C4598FB1AAC1Q39490886-CEA7CB48-849A-423D-A549-BCB3A855B538Q39909349-36318F30-F82D-4E36-B0F5-BDAE21928699Q39959030-DB1CC916-67AF-4FE2-BC50-6D08A4281B2EQ40706312-DF98B776-365D-4F5F-955B-B80C6C65E16BQ42031640-9B921FEF-AB4A-41E9-AC5B-E5F8ACECD771Q43280507-A6367BD5-866D-4F6F-B74F-C129A7B204EDQ45409915-238954AE-9CE4-489B-B86F-8C5713F79432Q50651011-B22EFB1F-EBEE-4D50-8268-23CC02E301CFQ50976881-12ABFE44-FACE-43E5-85F9-677211345029Q51057526-DCCF8A4C-ED27-464A-9279-B0462C83540DQ56788902-F3B6177B-60CC-4D96-8550-5AC1C3B596CAQ91710777-540E1632-5E6E-4509-88CB-6DD1233CBFBCQ92595454-5A3175E2-8BDE-4F6B-AE64-744606E78651
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Prisca Boisguerin
@ast
Prisca Boisguerin
@en
Prisca Boisguerin
@es
Prisca Boisguerin
@nl
Prisca Boisguerin
@sl
type
label
Prisca Boisguerin
@ast
Prisca Boisguerin
@en
Prisca Boisguerin
@es
Prisca Boisguerin
@nl
Prisca Boisguerin
@sl
prefLabel
Prisca Boisguerin
@ast
Prisca Boisguerin
@en
Prisca Boisguerin
@es
Prisca Boisguerin
@nl
Prisca Boisguerin
@sl
P108
P106
P1153
6506848132
P31
P496
0000-0002-6955-1340